Literature DB >> 11851902

Incident hepatitis C virus infection in a community-based population in Japan.

A Okayama1, S O Stuver, E Tabor, N Tachibana, M Kohara, N E Mueller, H Tsubouchi.   

Abstract

Hepatitis C virus (HCV) is an important cause of liver disease throughout the world. However, the natural history and pathogenesis of this infection is still not completely understood. The aim of this study was to characterize the evolution of incident, asymptomatic HCV infection in a community-based population in Japan. The Miyazaki Cohort Study is a prospective study of adult residents in two villages, one of which has a very high prevalence of HCV. Nine hundred and seventy-three people from this village were enrolled in the cohort between 1984 and 1995, with antibodies to HCV (anti-HCV) found in 23%. During subsequent visits to annual health screens, new HCV seroconverters were identified among susceptible individuals, and their sequential samples were tested for anti-HCV, HCV-RNA, and HCV core antigen. Fourteen participants (six males, eight females) acquired anti-HCV during the first 11 years of study follow-up, at an incidence rate of 362 per 100 000 person-years. Detectable HCV-RNA and high anti-HCV titres (> 1:2048) were observed for more than 5 years following seroconversion in 80% (8/10) of seroconverters with sufficient information, indicating the development of persistent infection in these subjects. Three (37.5%) of the eight sero converters with persistent infection had fairly consistent, albeit mild, alanine aminotransferase elevations (30-130 IU/L) during the study. Anti-HCV seroconversions occurred at a very high rate in this community-based population in Japan, in which this infection is endemic. Persistence also developed at a high frequency among the cases of newly acquired infection, although the associated liver enzyme abnormalities were mild.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11851902     DOI: 10.1046/j.1365-2893.2002.00331.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  11 in total

1.  Hepatitis C, a silent threat to the community of Haryana, India: a community-based study.

Authors:  Ramesh Verma; Binod Kumar Behera; R B Jain; Varun Arora; Vinod Chayal; P S Gill
Journal:  Australas Med J       Date:  2014-01-31

Review 2.  Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens.

Authors:  Umberto Vespasiani-Gentilucci; Giovanni Galati; Paolo Gallo; Antonio De Vincentis; Elisabetta Riva; Antonio Picardi
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

3.  Incidence and risk factors for community-acquired hepatitis C infection from birth to 5 years of age in rural Egyptian children.

Authors:  Doa'a A Saleh; Fatma M Shebl; Samer S El-Kamary; Laurence S Magder; Alif Allam; Mohamed Abdel-Hamid; Nabiel Mikhail; Mohamed Hashem; Soraya Sharaf; Sonia K Stoszek; G Thomas Strickland
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-02-12       Impact factor: 2.184

4.  Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users.

Authors:  J Amin; M G Law; J Micallef; M Jauncey; I Van Beek; J M Kaldor; G J Dore
Journal:  Epidemiol Infect       Date:  2006-05-17       Impact factor: 2.451

Review 5.  Epidemiology of hepatitis C virus infection.

Authors:  Miriam J Alter
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

6.  The evolutionary patterns of hepatitis C virus subtype 2a and 6a isolates linked to an outbreak in China in 2012.

Authors:  Ling Lu; Yuling An; Ji Zou; Lin Gu; Zhixin Zhao; Xiaohong Zhang; Chunhua Li; Chie Kurihara; Ryota Hokari; Jun Itakura; Masayuki Kurosaki; Namiki Izumi; Yongshui Fu; Tatsunori Nakano; Takanobu Kato; Francesco Negro; Guihua Chen
Journal:  Virology       Date:  2015-09-07       Impact factor: 3.616

Review 7.  Hepatitis C virus infection in the elderly: epidemiology, natural history and management.

Authors:  Francesca Cainelli
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 8.  Epidemiology and natural history of hepatitis C virus infection.

Authors:  Mei-Hsuan Lee; Hwai-I Yang; Yong Yuan; Gilbert L'Italien; Chien-Jen Chen
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

9.  The effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patients.

Authors:  Hiroki Nishikawa; Eriko Iguchi; Yorimitsu Koshikawa; Soichiro Ako; Tadashi Inuzuka; Haruhiko Takeda; Jun Nakajima; Fumihiro Matsuda; Azusa Sakamoto; Sinichiro Henmi; Keiichi Hatamaru; Tetsuro Ishikawa; Sumio Saito; Ryuichi Kita; Toru Kimura; Yukio Osaki
Journal:  BMC Res Notes       Date:  2012-03-10

10.  Increasing newly diagnosed rate and changing risk factors of HCV in Yanbian Prefecture, a high endemic area in China.

Authors:  Hong-Xin Piao; Ai-Ting Yang; Ya-Meng Sun; Yuan-Yuan Kong; Xiao-Ning Wu; Ying-Zhe Zhang; Bo Ding; Bao-En Wang; Ji-Dong Jia; Hong You
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.